Overview


According to FutureWise analysis, the market for Alternatives for Injectable Diabetes Care is expected to grow at a CAGR of 9.52% over the forecast period of 2023-2031.

Alternative treatments for diabetes management have been developed to provide individuals with more options and improve their quality of life. One such alternative is the use of oral medications. Instead of injections, individuals can take prescribed oral antidiabetic drugs, such as metformin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These medications work by increasing insulin production in the pancreas, improving insulin sensitivity, or reducing glucose production in the liver. By taking these medications in pill form, individuals can conveniently manage their diabetes without the need for injections. 

Another alternative to injectable diabetes care is the use of insulin pumps. Insulin pumps are small devices that deliver insulin through a catheter placed under the skin, typically on the abdomen. These pumps provide continuous subcutaneous insulin infusion, mimicking the body's natural insulin production. They offer precise control over insulin delivery and allow for customizable basal rates and bolus dosing. With an insulin pump, individuals can adjust their insulin dosage based on their needs and lifestyle, administering additional insulin before meals or as required. The advantage of insulin pumps is that they reduce the frequency of injections, as the catheter only needs to be changed every few days. Another alternative is inhalable insulin, such as Afrezza. This form of insulin comes in a powdered form that is inhaled into the lungs, providing a rapid-acting option for controlling blood sugar levels. It can be taken before meals and offers convenience compared to traditional injections. Therefore, individuals with diabetes have alternative options to manage their condition without relying solely on injectable medications.

FutureWise Market Research has published a report that provides an insightful analysis of alternatives for injectable diabetes care market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that alternatives for injectable diabetes care market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Animas Corporation
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic plc.
  • Valeritas, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Alternatives for Injectable Diabetes Care Market:

  • In March 2022, Medtronic India recently launched the MiniMed 780G System, which is an innovative closed-loop insulin pump designed to manage type 1 diabetes in patients between the ages of 7-80. The SmartGuard technology integrated into the system automates the delivery of basal insulin and correction boluses every five minutes, making it easier for people with diabetes to avoid high or low blood sugar levels.

The alternatives for injectable diabetes care market is a complex and ever-evolving space that is impacted by a multitude of factors. Several key drivers are currently influencing the market's growth and development, including the rising adoption of innovative continuous glucose monitoring systems and non-invasive insulin delivery methods. These advancements are transforming the demand for injectable treatments as patients seek more effective and convenient options for managing their condition. Another significant factor shaping the market is the emergence of artificial pancreas systems, which combine continuous glucose monitoring and insulin delivery in a closed-loop system. These systems have the potential to revolutionize diabetes care by automating insulin dosing and reducing the risk of hypoglycemia. In addition, personalized medicine and precision diabetes care are also gaining traction, as healthcare providers seek to personalized treatments to each patient's unique needs and characteristics. At the same time, regulatory changes, pricing fluctuations, market consolidation, and consumer preferences for lifestyle modifications can all impact the alternatives for injectable diabetes care market. For example, changes in regulatory requirements can impact the availability and pricing of certain treatments, while market consolidation can lead to increased competition and pricing pressures. Consumer preferences for lifestyle modifications, such as diet and exercise, can also impact the demand for injectable treatments.

By Product Type

  • Insulin Pumps
  • Untethered Insulin Pumps
  • Implantable Insulin Pump
  • Tethered Insulin Pumps
  • Artificial Pancreas
  • Insulin Patches

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Diabetes Clinics/ Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America holds a dominant position in the global alternatives for injectable diabetes care market, mainly due to the high prevalence of diabetes in the region, driven by sedentary lifestyles. Additionally, the launch of new drugs in North America further contributes to its market leadership. Within north America, the United States is expected to experience significant growth during the forecast period. This growth is attributed to factors like the high prevalence of obesity and increased awareness regarding diabetes care in the country. Moreover, north America remains the largest market for insulin drugs, primarily due to the strong demand from the United States.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Alternatives For Injectable Diabetes Care Market By Product Type, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Alternatives For Injectable Diabetes Care Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Alternatives For Injectable Diabetes Care Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Alternatives For Injectable Diabetes Care Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Alternatives For Injectable Diabetes Care Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Insulin Pumps
        2. Untethered Insulin Pumps
        3. Implantable Insulin Pump
        4. Tethered Insulin Pumps
        5. Artificial Pancreas
        6. Insulin Patches

  • 8.   Alternatives For Injectable Diabetes Care Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Sales
        4. Diabetes Clinics/ Centers

  • 9.   North America Alternatives For Injectable Diabetes Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Alternatives For Injectable Diabetes Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Alternatives For Injectable Diabetes Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Alternatives For Injectable Diabetes Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Alternatives For Injectable Diabetes Care Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Animas Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. F. Hoffmann-La Roche AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Insulet Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Medtronic plc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Valeritas, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Diabetes Care Devices Market

Read More

Pet Diabetes Care Market

Read More
Partner

Our Clients